Trials / Completed
CompletedNCT00692250
A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy Volunteers
A Phase I Open Label, Randomised, Single Dose, 2-way Crossover, 2-Sequence Pharmacokinetic Study on the Interaction of Colesevelam and Ciclosporin in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Genzyme, a Sanofi Company · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is designed to assess any potential interaction between colesevelam and ciclosporin in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colesevelam hydrochloride film-coated tablets (Cholestagel) |
Timeline
- Start date
- 2007-09-01
- Completion
- 2007-12-01
- First posted
- 2008-06-06
- Last updated
- 2015-05-05
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00692250. Inclusion in this directory is not an endorsement.